宏元生物通过与上海长海等医院泌尿外科达成合作,进行了UroCAD的临床验证(国际临床试验编号:NCT03998371)<ref>[https://clinicaltrials.gov/ct2/show/NCT03998371 Application of UCAD for Diagnosing Urothelial Carcinoma.]</ref>。CancerNetwork有评论显示据初步结论显示,UroCAD具备在做膀胱镜检测前,作为无创方法用于尿路上皮癌患者的诊断和复发监测,从而大大减轻了患者的负担<ref>[https://www.cancernetwork.com/view/urocad-outperforms-urine-cytology-in-detecting-urothelial-carcinoma UroCAD Outperforms Urine Cytology in Detecting Urothelial Carcinoma]</ref>。 | 宏元生物通过与上海长海等医院泌尿外科达成合作,进行了UroCAD的临床验证(国际临床试验编号:NCT03998371)<ref>[https://clinicaltrials.gov/ct2/show/NCT03998371 Application of UCAD for Diagnosing Urothelial Carcinoma.]</ref>。CancerNetwork有评论显示据初步结论显示,UroCAD具备在做膀胱镜检测前,作为无创方法用于尿路上皮癌患者的诊断和复发监测,从而大大减轻了患者的负担<ref>[https://www.cancernetwork.com/view/urocad-outperforms-urine-cytology-in-detecting-urothelial-carcinoma UroCAD Outperforms Urine Cytology in Detecting Urothelial Carcinoma]</ref>。 |